Iron deficiency is the most common nutritional disorder in the world, affecting approximately 25% of the world’s population, and the most common cause of anemia. Iron deficiency may be treated with intravenous iron therapy. We have thoroughly researched the complexities of iron preparations and has established robust methodologies for evaluating Iron-Carbohydrate preparations. Our work on Iron sucrose, Ferric carboxy maltose and ferrous sulphate bioanalysis demonstrates how Navitas Life Sciences addresses customer expectations in a regulated bioanalysis environment to bring their iron preparation to the market faster.
We have conducted 1400+ Bioequivalence studies, with over 100 marketing authorizations, and have developed some 400+ bioanalytical methods. We follow Good Clinical Practices (GCP) and Good Laboratory Practices (GLP) and are ISO 9001-2015 and ISO 27001-2013 certified for our Quality Management System. Our clinical testing laboratories are also certified by both The National Accreditation Board for Testing and Calibration Laboratories (NABL) and the College of American Pathologists (CAP).
Please complete the form to download our Total Iron and Transferrin bound Iron assay brochure and learn how you can leverage our experience and reliable bioanalytical methods expertise to support the evaluation of your bioequivalence and/or safety studies.